Guanylhydrazones and their use to treat inflammatory conditions
    6.
    发明授权
    Guanylhydrazones and their use to treat inflammatory conditions 失效
    桂脒及其用于治疗炎症的用途

    公开(公告)号:US06180676B2

    公开(公告)日:2001-01-30

    申请号:US08472003

    申请日:1995-06-06

    IPC分类号: A61K3117

    摘要: This invention concerns new methods and compositions that are useful in preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More particularly, the invention relates to aromatic guanylhydrazone (more properly termed amidinohydrazone) compositions and their use to inhibit the uptake of arginine by macrophages and/or its conversion to urea. These compositions and methods are also useful in preventing the generation of nitric oxide (NO) by cells, and so to prevent NO-mediated inflammation and other responses in persons in need of same. In another embodiment, the compounds can be used to inhibit arginine uptake in arginine-dependent tumors and infections.

    摘要翻译: 本发明涉及可用于预防和改善恶病质的新方法和组合物,与癌症和其它慢性疾病相关的营养状况不佳的临床综合征以及身体的消耗。 更具体地说,本发明涉及芳香脒腙(更合适地称为脒基腙)组合物及其用于抑制巨噬细胞摄取精氨酸和/或转化成尿素的用途。 这些组合物和方法也可用于预防细胞产生一氧化氮(NO),并且因此可以防止需要相同的人的NO介导的炎症和其他反应。 在另一个实施方案中,所述化合物可用于抑制精氨酸依赖性肿瘤和感染中的精氨酸摄取。